LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the world's largest international healthcare and medical technology trade fairs. The company, which focuses on telehealth infrastructure and healthcare analytics platforms for emerging markets, views participation as a key component of its ongoing evaluation of healthcare technologies, strategic industry relationships, and commercialization opportunities.
Management stated that attending MEDICA supports the company's efforts to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, AI-focused healthcare companies, and other industry stakeholders from Europe, Latin America, and other international markets. The company believes that involvement in global healthcare events provides opportunities to evaluate emerging technologies, foster industry relationships, and advance its long-term digital healthcare infrastructure strategy across Latin America and other developing regions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., emphasized the importance of technology-driven healthcare models. "Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America," he said.
The company remains in the development and commercialization stage for certain aspects of its healthcare technology platform and business operations. It cautioned that attendance at industry conferences does not guarantee strategic relationships, commercial agreements, financing arrangements, technology integrations, revenue generation, or future operational success.
LataMed AI Corp. continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts as part of its long-term digital healthcare ecosystem strategy. The company's focus on Latin America aims to address the region's healthcare challenges through scalable digital solutions.
For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.